UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Alemtuzumab-induced remission of multiple sclerosis-associated uveitis

Willis, MD; Pickersgill, TP; Robertson, NP; Lee, RW; Dick, AD; Carreño, E; (2017) Alemtuzumab-induced remission of multiple sclerosis-associated uveitis. International Ophthalmology , 37 (5) pp. 1229-1233. 10.1007/s10792-016-0370-9. Green open access

[thumbnail of dick_Int ophthalmol - Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.pdf]
Preview
Text
dick_Int ophthalmol - Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.pdf

Download (329kB) | Preview

Abstract

PURPOSE: The purpose of the study was to report a case of multiple sclerosis (MS)-associated uveitis refractory to conventional immunosuppressants, with subsequent remission following treatment with alemtuzumab. METHODS: Case report Patient was treated with intravenous alemtuzumab, a lymphocyte depleting anti-CD52 monoclonal antibody that has recently been approved for use in relapsing MS. RESULTS: A 17-year-old female presented with bilateral optic neuritis and subsequently bilateral intermediate uveitis and secondary macular oedema. She was diagnosed with active relapsing MS for which she received treatment with alemtuzumab. The intraocular inflammation previously refractory to conventional immunosuppressants responded to alemtuzumab, inducing remission. CONCLUSIONS: To our knowledge, this is the first such report of alemtuzumab treatment in MS-associated ocular inflammatory disease and may demonstrate a potential utility for this drug in related conditions.

Type: Article
Title: Alemtuzumab-induced remission of multiple sclerosis-associated uveitis
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s10792-016-0370-9
Publisher version: http://dx.doi.org/10.1007/s10792-016-0370-9
Language: English
Additional information: The final publication is available at Springer via http://dx.doi.org/10.1007/s10792-016-0370-9
Keywords: Alemtuzumab, Intraocular inflammation, Multiple sclerosis, Uveitis
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/1522464
Downloads since deposit
11,165Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item